DETERMINATION OF DOXORUBICIN IN HUMAN BLOOD PLASMA AND URINE USING AMPEROMETRY FOR ONCOLOGY PATIENTS
The study aimed to analyze doxorubicin in blood serum, urine, and biological fluids as a potential new marker of toxicity, particularly in overweight patients receiving doxorubicin. The study involved 10 cancer patients receiving palliative treatment with doxorubicin. Amperometric titration was used to determine doxorubicin levels in urine, blood, and biological samples.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-04-03
- DOI
- https://doi.org/10.5281/zenodo.15128512
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00